Posterior Cervical Fusion with Recombinant Human Bone Morphogenetic Protein-2

Clinical Spine Surgery

Volumn 29, Issue 6, 2016, Pages E276-E281

  Dorward, Ian G ^a   Buchowski, Jacob M ^a   Stoker, Geoffrey E ^a   Zebala, Lukas P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fusion rates; posterior cervical fusion; pseudarthrosis; rhBMP 2

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; STEROID; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARM WEAKNESS; ARTICLE; AUTOGRAFT; BASILAR INVAGINATION; BONE PROSTHESIS; BONY BRIDGING; CERVICAL SPINE RADIOGRAPHY; CERVICAL SPONDYLOSIS; CERVICOBRACHIAL NEURALGIA; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIABETES MELLITUS; DISABLED PERSON; DISCECTOMY; FEMALE; FOLLOW UP; FORAMINOTOMY; FRACTURE NONUNION; HUMAN; ILIAC CREST; ILIAC CREST AUTOGRAFT; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NECK DISABILITY INDEX; NECK PAIN; NEUROLOGIC DISEASE; OSTEOTOMY; PARESTHESIA; PEDICLE SCREW; PEDICLE SUBTRACTION OSTEOTOMY; PENSIONER; POSTERIOR CERVICAL FUSION; POSTERIOR SPINE FUSION; POSTOPERATIVE COMPLICATION; PSEUDARTHROSIS; RADICULAR PAIN; RADIOLUCENCY AROUND INSTRUMENTATION; RANGE OF MOTION; REOPERATION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEROMA; SHOULDER PAIN; SUBLUXATION; SURGICAL INFECTION; UNEMPLOYMENT; VISUAL ANALOG SCALE; WOUND DEHISCENCE; WOUND IRRIGATION; CERVICAL VERTEBRA; LONGITUDINAL STUDY; RISK FACTOR; SPINE DISEASE; SPINE FUSION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 2; CERVICAL VERTEBRAE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PSEUDARTHROSIS; RECOMBINANT PROTEINS; RISK FACTORS; SPINAL DISEASES; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84992159544     PISSN: 23800186     EISSN: 23800194     Source Type: Journal    
DOI: 10.1097/BSD.0b013e318286fa7e     Document Type: Article

References (30)

1. Liu JK, Das K. Posterior fusion of the subaxial cervical spine: indications and techniques. Neurosurg Focus. 2001;10:E7.
2. Carreon L, Glassman SD, Campbell MJ. Treatment of anterior cervical pseudoarthrosis: posterior fusion versus anterior revision. Spine J. 2006;6:154-156.
3. Hasegawa K, Hirano T, Shimoda H, et al. Indications for cervical pedicle screw instrumentation in nontraumatic lesions. Spine (Phila Pa 1976). 2008;33:2284-2289.
4. Kuhns CA, Geck MJ, Wang JC, et al. An outcomes analysis of the treatment of cervical pseudarthrosis with posterior fusion. Spine (Phila Pa 1976). 2005;30:2424-2429.
5. Kwon BK, Fisher CG, Boyd MC, et al. A prospective randomized controlled trial of anterior compared with posterior stabilization for unilateral facet injuries of the cervical spine. J Neurosurg Spine. 2007;7:1-12.
6. Yoshimoto H, Sato S, Hyakumachi T, et al. Spinal reconstruction using a cervical pedicle screw system. Clin Orthop Relat Res. 2005;431:111-119.
7. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine (Phila Pa 1976). 2003;28:1219-1224; discussion 25.
8. Boakye M, Mummaneni PV, Garrett M, et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine. 2005;2:521-525.
9. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976). 2002;27:2662-2673.
10. Burkus JK, Heim SE, Gornet MF, et al. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics. 2004;27:723-728.
11. Lanman TH, Hopkins TJ. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(L-lactide-co-D,Llactide) bioabsorbable implants. Neurosurg Focus. 2004;16:E6.
12. Lovell TP, Dawson EG, Nilsson OS, et al. Augmentation of spinal fusion with bone morphogenetic protein in dogs. Clin Orthop Relat Res. 1989;243:266-274.
13. Sandhu HS. Bone morphogenetic proteins and spinal surgery. Spine (Phila Pa 1976). 2003;28:S64-S73.
14. Sandhu HS, Khan SN. Recombinant human bone morphogenetic protein-2: use in spinal fusion applications. J Bone Joint Surg Am. 2003;85-A(suppl 3):89-95.
15. Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J. 2007;7:301-307.
16. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A. 1988;85:9484-9488.
17. Ong KL, Villarraga ML, Lau E, et al. Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976). 2010;35:1794-1800.
18. Papakostidis C, Kontakis G, Bhandari M, et al. Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results. Spine (Phila Pa 1976). 2008;33:E680-E692.
19. Shen HX, Buchowski JM, Yeom JS, et al. Pseudarthrosis in multilevel anterior cervical fusion with rhBMP-2 and allograft: analysis of one hundred twenty-seven cases with minimum two-year follow-up. Spine (Phila Pa 1976). 2010;35:747-753.
20. Benglis D, Wang MY, Levi AD. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery. 2008;62:ONS423-ONS431; discussion ONS31.
21. Perri B, Cooper M, Lauryssen C, et al. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J. 2007;7:235-239.
22. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006;31:542-547.
23. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006;31:2813-9.
24. Vaidya R, Sethi A, Bartol S, et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech. 2008;21:557-562.
25. Hamilton DK, Smith JS, Reames DL, et al. Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up. Neurosurgery. 2011;69:103-111; discussion 11.
26. Vernon H, Mior S. The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther. 1991;14:409-415.
27. Crawford CH III, Carreon LY, McGinnis MD, et al. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Spine (Phila Pa 1976). 2009;34:1390-1394.
28. Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine (Phila Pa 1976). 2009;34:885-889.
29. Lenke LG, Bridwell KH, Bullis D, et al. Results of in situ fusion for isthmic spondylolisthesis. J Spinal Disord. 1992;5:433-442.
30. Huang RC, Girardi FP, Poynton AR, et al. Treatment of multilevel cervical spondylotic myeloradiculopathy with posterior decompression and fusion with lateral mass plate fixation and local bone graft. J Spinal Disord Tech. 2003;16:123-129.